Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    "methodist hospital" AND ebv-specific cytotoxic t-lymphocyte | Open Studies | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Recruiting Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)
Conditions: Hodgkin Disease;   Non-Hodgkin Lymphoma;   Severe Chronic Active Epstein Barr Virus;   T/NK-lymphoproliferative Disease
Interventions: Biological: MABEL CTLs;   Drug: Cyclophosphamide;   Drug: Fludarabine
2 Recruiting Nivolumab With Epstein Barr Virus Specific T Cells (EB-VSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)
Conditions: NonHodgkin Lymphoma;   Lymphoproliferative Disorders;   EBV Related Lymphoma;   EBV-Related PTLD;   Hodgkin Lymphoma;   EBV Related Non-Hodgkin's Lymphoma;   EBV Related Hodgkin's Lymphoma
Interventions: Biological: EB-VST Cells;   Biological: Nivolumab

Study has passed its completion date and status has not been verified in more than two years.